Skip to main content
SpringerLink
Log in

Adalimumab/infliximab

Disseminated tuberculosis and treatment failure: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ntiri M, et al. Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa. JAAD Case Reports 29: 76-79, Nov 2022. Available from: URL: http://doi.org/10.1016/j.jdcr.2022.08.048

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab. Reactions Weekly 1943, 23 (2023). https://doi.org/10.1007/s40278-023-32908-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32908-2

Search

Navigation